EE100 Treatment-Related Lost Productivity in Paroxysmal Nocturnal Hemoglobinuria: A Comparison of Investigational Subcutaneous Ravulizumab and Pegcetacoplan in the United States
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.353
https://www.valueinhealthjournal.com/article/S1098-3015(22)00554-X/fulltext
Title :
EE100 Treatment-Related Lost Productivity in Paroxysmal Nocturnal Hemoglobinuria: A Comparison of Investigational Subcutaneous Ravulizumab and Pegcetacoplan in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00554-X&doi=10.1016/j.jval.2022.04.353
First page :
Section Title :
Open access? :
No
Section Order :
10309